Department of Pathology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Shanghai Histo Pathology Diagnosis Center, Shanghai, China.
Pathol Int. 2021 Mar;71(3):183-190. doi: 10.1111/pin.13067. Epub 2021 Jan 27.
Interferon regulatory factor 4 (IRF4) rearrangement is commonly detected in patients with a range of lymphoproliferative malignancies, including myelomas, large B cell lymphomas and low-grade B cell neoplasms. However, IRF4 rearrangement is generally a relatively rare finding in these latter two cancer types. In the present article, we describe and summarize the clinicopathological and genetic features of 13 cases of B cell lymphoma with IRF4 rearrangement, including 12 cases of large B cell lymphoma and one case of low-grade lymphoma exhibiting such rearrangement. These cases were detected in six females and seven males between 14 and 71 years of age. From a morphological perspective, large B cell lymphoma tumors included in this analysis exhibited large neoplastic cells in diffuse or follicular patterns, while the case of low-grade lymphoma mainly composed of small lymphocytes. All analyzed cases exhibited a split in the IRF4 gene consistent with IRF4 translocation. Three of six analyzed large B cell lymphoma cases harbored IGLL5 mutations. Mutations in SAMHD1 were detected in the low-grade lymphoma with IRF4 rearrangement case. In summary, our results offer further insight into the morphological and molecular heterogeneity of cases of B cell lymphoma exhibiting IRF4 rearrangements.
干扰素调节因子 4(IRF4)重排常见于多种淋巴增殖性恶性肿瘤患者,包括骨髓瘤、大 B 细胞淋巴瘤和低级别 B 细胞肿瘤。然而,IRF4 重排在后两种癌症类型中通常是一种相对罕见的发现。在本文中,我们描述并总结了 13 例具有 IRF4 重排的 B 细胞淋巴瘤的临床病理和遗传学特征,包括 12 例大 B 细胞淋巴瘤和 1 例具有这种重排的低级别淋巴瘤。这些病例发生于 6 名女性和 7 名男性,年龄 14 至 71 岁。从形态学角度来看,本分析中包含的大 B 细胞淋巴瘤肿瘤表现为弥漫性或滤泡性的大肿瘤细胞,而低级别淋巴瘤主要由小淋巴细胞组成。所有分析的病例均表现出与 IRF4 易位一致的 IRF4 基因分裂。在 6 例分析的大 B 细胞淋巴瘤病例中,有 3 例存在 IGLL5 突变。具有 IRF4 重排的低级别淋巴瘤中检测到 SAMHD1 突变。总之,我们的结果进一步深入了解了具有 IRF4 重排的 B 细胞淋巴瘤病例的形态和分子异质性。